Editas Medicine, INC. (EDIT) SEC Filings — 2024

Filings

• Editas Medicine Announces Executive & Board Changes — 8-K · Dec 17, 2024
• Bristol Myers Squibb to Acquire Editas Medicine for $1.5 Billion — 8-K · Dec 12, 2024
• Editas Medicine Files 8-K with Corporate Updates — 8-K · Dec 10, 2024
• Editas Medicine, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Editas Medicine Files 8-K for Financials — 8-K · Nov 4, 2024
• Editas Medicine, INC. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• Editas Medicine Files 8-K on Operations and Financials — 8-K · Oct 22, 2024
• Editas Medicine, INC. SC 13G/A Filing — SC 13G/A · Oct 17, 2024
• Editas Medicine Files 8-K with Material Agreement — 8-K · Oct 4, 2024
• Editas Medicine Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
• Editas Medicine, INC. SC 13G/A Filing — SC 13G/A · Jul 10, 2024
• Editas Medicine Announces Executive and Board Changes — 8-K · Jun 27, 2024
• Editas Medicine Files 8-K Report — 8-K · Jun 14, 2024
• Editas Medicine Files 8-K on Shareholder Vote Matters — 8-K · May 31, 2024
• Editas Medicine Files 8-K on Financials — 8-K · May 8, 2024
• Editas Medicine Files DEF 14A for Annual Meeting and Executive Compensation — DEF 14A · Apr 16, 2024
• Editas Medicine, INC. SC 13G/A Filing — SC 13G/A · Apr 10, 2024
• Editas Medicine Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
• Editas Medicine, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Editas Medicine, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• BlackRock Amends Editas Medicine Stake, Maintains Passive Position — SC 13G/A · Jan 24, 2024
• State Street Corp. Maintains Passive Stake in Editas Medicine — SC 13G/A · Jan 10, 2024